HeartSciences (HSCS) investor holds 265,218 shares, 8.1%

Rhea-AI Filing Summary

HeartSciences Inc. reports a Schedule 13G filing showing beneficial ownership. Ephraim G. Fields 06/23/2026 beneficially owned 265,218 shares of Common Stock, representing 8.1%. The filing lists sole voting and dispositive power over the same 265,218 shares.

Insights

Governance Analyst

Significant passive stake reported by an individual holder.

The filing shows Ephraim G. Fields beneficially owns 265,218 shares or 8.1% as of 06/23/2026. This level commonly requires monitoring for ownership thresholds and disclosure obligations.

Future filings could clarify whether the position is passive or strategic; subsequent amendments would show changes in voting intent or plans.

Securities Compliance Attorney

Disclosure aligns with Schedule 13G reporting conventions for an investor stake.

The form identifies sole voting and dispositive power for 265,218 shares and provides the filer’s address and citizenship details. The filing includes CUSIP 42254E104 and signature dated 06/23/2026.

Legal significance is procedural; any material change in ownership or intent would trigger amendment obligations under applicable rules.

Key Figures

Shares beneficially owned: 265,218 shares Percent of class: 8.1% Filing date: 06/23/2026 +1 more

4 metrics

Shares beneficially owned 265,218 shares Reported as beneficially owned

Percent of class 8.1% Percent of common stock beneficially owned

Filing date 06/23/2026 Signature date on Schedule 13G

CUSIP 42254E104 Identifier for HeartSciences common stock

Key Terms

Schedule 13G, Beneficially owned, Sole dispositive power

3 terms

Schedule 13G regulatory

"Schedule 13G filing showing beneficial ownership (line: form_type)"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

Beneficially owned financial

"Amount beneficially owned: 265,218 (Item 4)"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 265,218"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/24/2026 - 08:03 AM Accepted by SEC EDGAR 06/24/2026 - 08:00 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

HeartSciences Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

42254E104

(CUSIP Number)

06/23/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 42254E104

1

Names of Reporting Persons

Fields Ephraim G

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 265,218.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 265,218.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

265,218.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.1 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: HeartSciences Inc.
(b)	Address of issuer's principal executive offices: 550 Reserve Street, Suite 360, Southlake, Texas 76092
Item 2.
(a)	Name of person filing: Ephraim Fields
(b)	Address or principal business office or, if none, residence: 265 E. 66th street, 36th Floor, NY, NY 10065
(c)	Citizenship: USA
(d)	Title of class of securities: Common Stock
(e)	CUSIP Number(s): 42254E104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 265,218
(b)	Percent of class: 8.1%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 265,218
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 265,218
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Fields Ephraim G

Signature:	/s/ Ephraim G Fields
Name/Title:	Ephraim G Fields
Date:	06/23/2026

FAQ

What stake does Ephraim G. Fields report in HeartSciences (HSCS)?

Ephraim G. Fields reports beneficial ownership of 265,218 shares, equal to 8.1% of common stock as of 06/23/2026. The filing states he has sole voting and dispositive power over those shares.

What form did HeartSciences receive for this disclosure (HSCS)?

The disclosure is a Schedule 13G filed for beneficial ownership, signed on 06/23/2026. It reports ownership details and voting/dispositive powers rather than a trading transaction or Form 4-style insider trade.

Does the filing indicate whether the shares were bought or sold?

The Schedule 13G reports ownership levels and control powers but does not state a purchase or sale. It lists the holder’s current beneficial ownership of 265,218 shares as of 06/23/2026 without transaction direction.

What specific control powers does the filer state for HSCS shares?

The filer declares sole voting power and sole dispositive power over 265,218 shares. The Schedule 13G shows zero shared voting or dispositive power for those shares.